Article
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
British journal of cancer - 11 Jul 2017
Forero-Castro Maribel, Robledo Cristina, Benito Rocío, Bodega-Mayor Irene, Rapado Inmaculada, Hernández-Sánchez María, Abáigar María, Maria Hernández-Sánchez Jesús, Quijada-Álamo Miguel, María Sánchez-Pina José, Sala-Valdés Mónica, Araujo-Silva Fernanda, Kohlmann Alexander, Luis Fuster José, Arefi Maryam, de Las Heras Natalia, Riesco Susana, Rodríguez Juan N, Hermosín Lourdes, Ribera Jordi, Camos Guijosa Mireia, Ramírez Manuel, de Heredia Rubio Cristina Díaz, Barragán Eva, Martínez Joaquín, Ribera José M, Fernández-Ruiz Elena, Hernández-Rivas Jesús-María
Abstract excerpt
BACKGROUND: In B-cell precursor acute lymphoblastic leukaemia (B-ALL), the identification of additional genetic alterations associated with poor prognosis is still of importance. We determined the frequency and prognostic impact of somatic mutations in children and adult cases with B-ALL treated with Spanish PETHEMA and SEHOP protocols. METHODS: Mutational status of hotspot regions of TP53, JAK2, PAX5, LEF1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
